Declining levels of HIV P24 antigen in serum during treatment with foscarnet.
D000163:Acquired Immunodeficiency Syndrome / Q000188:drug therapy / Q000276:immunology*; D000956:Antigens, Viral / Q000032:analysis*; D000998:Antiviral Agents / Q000627:therapeutic use*; D017245:Foscarnet; D006678:HIV / Q000276:immunology; D015488:HIV Antigens; D016655:HIV Core Protein p24; D006801:Humans; D008297:Male; D009943:Organophosphorus Compounds / Q000627:therapeutic use*; D010746:Phosphonoacetic Acid / Q000031:analogs & derivatives / Q000627:therapeutic use*; D012191:Retroviridae Proteins / Q000032:analysis*
D000956:Antigens, Viral; D000998:Antiviral Agents; D015488:HIV Antigens; D016655:HIV Core Protein p24; D009943:Organophosphorus Compounds; D012191:Retroviridae Proteins; D017245:Foscarnet; D010746:Phosphonoacetic Acid